Showing results (1131-1140 of 1,227) with videos related to

Sort By:
Pageof 123
SLAS Discovery : Advancing Life Sciences R & D|March 28, 2017
Screening of Intestinal Crypt Organoids: A Simple Readout for Complex BiologySvenja Ley, Olaf Galuba, Adrian Salathe, et al.
Clinical Breast Cancer|July 25, 2008
A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37Irene L Wapnir, Stefan Aebi, Charles E Geyer, et al.
BMJ Open|September 23, 2024
Cohort profile: the Swiss Mother and Child HIV Cohort Study (MoCHiV)Paolo Paioni, Murezi Capaul, Anja Brunner, et al.
Frontiers in Pediatrics|August 24, 2018
Time-to-Positivity of Blood Cultures in Children With SepsisAlexa Dierig, Christoph Berger, Philipp K A Agyeman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IXS Aebi, Z Sun, D Braun, et al.
Blood|August 15, 2002
A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)Urban Novak, Elisabeth Oppliger Leibundgut, Jörg Hager, et al.
The Lancet Regional Health. Europe|June 12, 2023
Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort studyPaolo Paioni, Karoline Aebi-Popp, Begoña Martinez de Tejada, et al.
British Journal of Cancer|November 29, 2007
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancerJ Bernhard, D Zahrieh, J J Zhang, et al.
Psychological Medicine|April 13, 2010
Predictability of oppositional defiant disorder and symptom dimensions in children and adolescents with ADHD combined typeM Aebi, U C Müller, P Asherson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99O Pagani, D Klingbiel, T Ruhstaller, et al.
Pageof 123